vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Talen Energy Corp (TLN). Click either name above to swap in a different company.

Talen Energy Corp is the larger business by last-quarter revenue ($758.0M vs $493.8M, roughly 1.5× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -47.9%, a 54.7% gap on every dollar of revenue. On growth, Talen Energy Corp posted the faster year-over-year revenue change (114.7% vs -1.7%). Over the past eight quarters, Talen Energy Corp's revenue compounded faster (35.0% CAGR vs -0.1%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

PPL Corporation is an energy company headquartered in Allentown, Pennsylvania in the Lehigh Valley region of eastern Pennsylvania. The company is publicly traded on the New York Stock Exchange as NYSE: PPL and is part of the S&P 500. As of 2022, the company had $7.9 billion in revenue, 6,500 employees, over $37 billion in assets, and serves 3.6 million customers.

MD vs TLN — Head-to-Head

Bigger by revenue
TLN
TLN
1.5× larger
TLN
$758.0M
$493.8M
MD
Growing faster (revenue YoY)
TLN
TLN
+116.4% gap
TLN
114.7%
-1.7%
MD
Higher net margin
MD
MD
54.7% more per $
MD
6.8%
-47.9%
TLN
Faster 2-yr revenue CAGR
TLN
TLN
Annualised
TLN
35.0%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MD
MD
TLN
TLN
Revenue
$493.8M
$758.0M
Net Profit
$33.7M
$-363.0M
Gross Margin
Operating Margin
9.9%
-41.3%
Net Margin
6.8%
-47.9%
Revenue YoY
-1.7%
114.7%
Net Profit YoY
10.5%
-542.7%
EPS (diluted)
$0.40
$-7.60

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
TLN
TLN
Q4 25
$493.8M
$758.0M
Q3 25
$492.9M
$697.0M
Q2 25
$468.8M
$409.0M
Q1 25
$458.4M
$654.0M
Q4 24
$502.4M
$353.0M
Q3 24
$511.2M
$459.0M
Q2 24
$504.3M
$346.0M
Q1 24
$495.1M
$416.0M
Net Profit
MD
MD
TLN
TLN
Q4 25
$33.7M
$-363.0M
Q3 25
$71.7M
$207.0M
Q2 25
$39.3M
$72.0M
Q1 25
$20.7M
$-135.0M
Q4 24
$30.5M
$82.0M
Q3 24
$19.4M
$168.0M
Q2 24
$-153.0M
$454.0M
Q1 24
$4.0M
$294.0M
Operating Margin
MD
MD
TLN
TLN
Q4 25
9.9%
-41.3%
Q3 25
13.8%
37.7%
Q2 25
12.8%
16.1%
Q1 25
7.0%
-16.2%
Q4 24
7.8%
4.5%
Q3 24
6.6%
34.4%
Q2 24
-31.3%
7.8%
Q1 24
3.2%
6.0%
Net Margin
MD
MD
TLN
TLN
Q4 25
6.8%
-47.9%
Q3 25
14.5%
29.7%
Q2 25
8.4%
17.6%
Q1 25
4.5%
-20.6%
Q4 24
6.1%
23.2%
Q3 24
3.8%
36.6%
Q2 24
-30.3%
131.2%
Q1 24
0.8%
70.7%
EPS (diluted)
MD
MD
TLN
TLN
Q4 25
$0.40
$-7.60
Q3 25
$0.84
$4.25
Q2 25
$0.46
$1.50
Q1 25
$0.24
$-2.94
Q4 24
$0.37
$2.07
Q3 24
$0.23
$3.16
Q2 24
$-1.84
$7.60
Q1 24
$0.05
$4.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
TLN
TLN
Cash + ST InvestmentsLiquidity on hand
$375.2M
$689.0M
Total DebtLower is stronger
$570.5M
$6.8B
Stockholders' EquityBook value
$865.9M
$1.1B
Total Assets
$2.2B
$10.9B
Debt / EquityLower = less leverage
0.66×
6.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
TLN
TLN
Q4 25
$375.2M
$689.0M
Q3 25
$340.1M
$497.0M
Q2 25
$224.7M
$122.0M
Q1 25
$99.0M
$295.0M
Q4 24
$229.9M
$328.0M
Q3 24
$103.8M
$648.0M
Q2 24
$19.4M
$632.0M
Q1 24
$8.0M
Total Debt
MD
MD
TLN
TLN
Q4 25
$570.5M
$6.8B
Q3 25
$577.2M
$3.0B
Q2 25
$583.9M
$3.0B
Q1 25
$590.5M
$3.0B
Q4 24
$597.1M
$3.0B
Q3 24
$2.6B
Q2 24
$2.6B
Q1 24
Stockholders' Equity
MD
MD
TLN
TLN
Q4 25
$865.9M
$1.1B
Q3 25
$890.7M
$1.5B
Q2 25
$833.8M
$1.2B
Q1 25
$789.2M
$1.2B
Q4 24
$764.9M
$1.4B
Q3 24
$732.5M
$2.4B
Q2 24
$706.5M
$2.5B
Q1 24
$856.2M
$2.8B
Total Assets
MD
MD
TLN
TLN
Q4 25
$2.2B
$10.9B
Q3 25
$2.2B
$6.1B
Q2 25
$2.1B
$5.8B
Q1 25
$2.0B
$5.9B
Q4 24
$2.2B
$6.1B
Q3 24
$2.1B
$6.8B
Q2 24
$2.0B
$7.1B
Q1 24
$2.2B
Debt / Equity
MD
MD
TLN
TLN
Q4 25
0.66×
6.23×
Q3 25
0.65×
2.03×
Q2 25
0.70×
2.40×
Q1 25
0.75×
2.54×
Q4 24
0.78×
2.17×
Q3 24
1.10×
Q2 24
1.05×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
TLN
TLN
Operating Cash FlowLast quarter
$114.1M
$280.0M
Free Cash FlowOCF − Capex
$254.0M
FCF MarginFCF / Revenue
33.5%
Capex IntensityCapex / Revenue
3.4%
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters
$606.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
TLN
TLN
Q4 25
$114.1M
$280.0M
Q3 25
$137.3M
$489.0M
Q2 25
$137.2M
$-184.0M
Q1 25
$-117.5M
$119.0M
Q4 24
$133.0M
Q3 24
$91.8M
$96.0M
Q2 24
$107.0M
$-23.0M
Q1 24
$-125.2M
$173.0M
Free Cash Flow
MD
MD
TLN
TLN
Q4 25
$254.0M
Q3 25
$468.0M
Q2 25
$-217.0M
Q1 25
$101.0M
Q4 24
Q3 24
$83.0M
Q2 24
$-43.0M
Q1 24
$148.0M
FCF Margin
MD
MD
TLN
TLN
Q4 25
33.5%
Q3 25
67.1%
Q2 25
-53.1%
Q1 25
15.4%
Q4 24
Q3 24
18.1%
Q2 24
-12.4%
Q1 24
35.6%
Capex Intensity
MD
MD
TLN
TLN
Q4 25
3.4%
Q3 25
3.0%
Q2 25
8.1%
Q1 25
2.8%
Q4 24
Q3 24
2.8%
Q2 24
5.8%
Q1 24
6.0%
Cash Conversion
MD
MD
TLN
TLN
Q4 25
3.39×
Q3 25
1.91×
2.36×
Q2 25
3.49×
-2.56×
Q1 25
-5.66×
Q4 24
4.36×
Q3 24
4.72×
0.57×
Q2 24
-0.05×
Q1 24
-31.03×
0.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

TLN
TLN

Electricity Sales And Ancillary Services$555.0M73%
Operating Revenue Capacity$182.0M24%
Physical Electricity Sales Bilateral Contracts Other$21.0M3%

Related Comparisons